Pages that link to "Q28286427"

The following pages link to Cystatin C and incident peripheral arterial disease events in the elderly: results from the Cardiovascular Health Study (Q28286427):

Displaying 43 items.

• A genome-wide association for kidney function and endocrine-related traits in the NHLBI's Framingham Heart Study (Q21261435) (← links)
• Heart Disease and Stroke Statistics--2015 Update: A Report From the American Heart Association (Q22241921) (← links)
• Heart Disease and Stroke Statistics--2010 Update: A Report From the American Heart Association (Q22306345) (← links)
• Heart Disease and Stroke Statistics--2013 Update: A Report From the American Heart Association (Q22306356) (← links)
• Cystatin C: a strong marker for lower limb ischemia in Chinese type 2 diabetic patients? (Q28534470) (← links)
• Heart disease and stroke statistics--2011 update: a report from the American Heart Association (Q29547236) (← links)
• Heart disease and stroke statistics--2014 update: a report from the American Heart Association (Q29547691) (← links)
• Heart disease and stroke statistics--2012 update: a report from the American Heart Association (Q29547909) (← links)
• Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association (Q30238784) (← links)
• Association of cystatin C with adverse outcomes. (Q33932292) (← links)
• Association of albumin-creatinine ratio and cystatin C with change in ankle-brachial index: the Multi-Ethnic Study of Atherosclerosis (MESA). (Q34747057) (← links)
• β2-microglobulin, cystatin C, and creatinine and risk of symptomatic peripheral artery disease (Q35026210) (← links)
• Higher cystatin C level predicts long-term mortality in patients with peripheral arterial disease. (Q35032801) (← links)
• A biomarker panel for peripheral arterial disease (Q35098249) (← links)
• Variation in the use of lower extremity vascular procedures for critical limb ischemia (Q35762765) (← links)
• Midlife Blood Pressure and Late-Life GFR and Albuminuria: An Elderly General Population Cohort (Q35893792) (← links)
• Cystatin C and asymptomatic coronary artery disease in patients with metabolic syndrome and normal glomerular filtration rate (Q36323314) (← links)
• Diagnosis and management of peripheral artery disease in women (Q36493454) (← links)
• Combined association of albuminuria and cystatin C-based estimated GFR with mortality, coronary heart disease, and heart failure outcomes: the Atherosclerosis Risk in Communities (ARIC) Study (Q36638809) (← links)
• Risk factors for peripheral arterial disease among patients with chronic kidney disease (Q36652294) (← links)
• Combined association of creatinine, albuminuria, and cystatin C with all-cause mortality and cardiovascular and kidney outcomes (Q36652786) (← links)
• Regional intensity of vascular care and lower extremity amputation rates (Q36864191) (← links)
• Cystatin C Predicts Incident Cardiovascular Disease in Twins (Q37076093) (← links)
• Renal dysfunction in burns: a review (Q37089078) (← links)
• Cystatin C in Acute Coronary Syndrome (Q37155015) (← links)
• Kidney function estimated from serum creatinine and cystatin C and peripheral arterial disease in NHANES 1999-2002. (Q37285963) (← links)
• Cystatin C: current position and future prospects (Q37313436) (← links)
• Rapid decline of kidney function increases cardiovascular risk in the elderly (Q37477773) (← links)
• Prognostic value of cystatin C in acute coronary syndromes: enhancer of atherosclerosis and promising therapeutic target (Q37878492) (← links)
• Effectiveness of bedside investigations to diagnose peripheral artery disease among people with diabetes mellitus: a systematic review. (Q38581275) (← links)
• Renal function and rate of hip bone loss in older men: the Osteoporotic Fractures in Men Study. (Q40105964) (← links)
• Assessing the clinical utility of biomarkers in medicine (Q40169397) (← links)
• High cystatin C levels predict undesirable outcome for diabetic foot ulcerations (Q40796648) (← links)
• Association between cystatin C and inflammation in patients with essential hypertension (Q42920664) (← links)
• Association between serum cystatin C levels and coronary slow flow (Q44212877) (← links)
• Is Serum Cystatin C a Predictor of Acute Pulmonary Thromboembolism in Patients With Normal Renal Function? (Q45935457) (← links)
• Cystatin C is associated with cardiovascular risk factors and metabolic syndrome in Aboriginal youth (Q51474303) (← links)
• Cystatin C, kidney function and cardiovascular disease. (Q55042196) (← links)
• High-sensitivity cardiac troponin and natriuretic peptide with risk of lower-extremity peripheral artery disease: the Atherosclerosis Risk in Communities (ARIC) Study (Q57178012) (← links)
• Chapter 4: Other complications of CKD: CVD, medication dosage, patient safety, infections, hospitalizations, and caveats for investigating complications of CKD (Q86553722) (← links)
• Chapter 5: Referral to specialists and models of care (Q86553726) (← links)
• Association between cystatin C gene polymorphism and the prevalence of white matter lesion in elderly healthy subjects (Q90317007) (← links)
• References (Q93609219) (← links)